Samara Capital secures a fresh contract in the banking, financial services, and insurance sector, focusing on control-oriented partnerships.
Samara Capital Expands Presence in Banking, Financial Services, and Insurance Sector
Samara Capital, a leading mid-market private equity firm based in India, has been making significant strides in the Banking, Financial Services, and Insurance (BFSI) sector. In a strategic move, Samara Capital has partnered with Norwest Venture Partners and Creador to form an investment platform that focuses on mid-market private equity transactions with a control orientation in BFSI companies.
The newly formed platform struck a new deal in the BFSI segment, although the details of the deal have not been disclosed. This partnership underscores Samara Capital's commitment to building scale and control in BFSI companies.
In a separate development, Samara Capital, through its affiliate Edme Services Private Ltd., acquired a minority stake in UIB Insurance Brokers (India) Pvt. Ltd. This deal is part of Edme's strategic vision to build a pan-India insurance distribution business. Edme will retain the core team to ensure continuity and further growth in the insurance brokerage sector.
Edme Insurance, backed by Samara Capital, is also planning an overseas foray. The location of this planned expansion is yet to be specified. To support this expansion drive, Edme may raise funds from internal accruals and existing investors.
Samara Capital's involvement in the BFSI sector is not limited to domestic markets. The firm is also eyeing more takeover targets overseas.
In addition to its BFSI investments, Samara Capital Markets Holding Limited is a significant shareholder in Sahajanand Medical Technologies, which filed for an IPO in mid-2025. This reflects Samara’s participation in growth-stage company investments with partial exits possibly planned through public markets.
Other firms in the news include Versuni India, SBI, Edelweiss Infra Fund, Samara Capital, and Lightbox. PE-backed SK Finance is seeking capital from an offshore investor before its planned IPO. On the other hand, the low demand is affecting the revenue of PE-backed Anjan Drug.
These actions illustrate Samara Capital's strong focus on building scale and control in BFSI companies, especially insurance distribution, and their intent to leverage both organic growth and acquisitions domestically and internationally.
- Samara Capital's strategic moves, such as forming a partnership and acquiring a minority stake in UIB Insurance Brokers, highlight their continued focus on finance, particularly in the Banking, Financial Services, and Insurance (BFSI) sector.
- Samara Capital's future plans also involve overseas expansion for Edme Insurance, further demonstrating their commitment to finance within the BFSI sector on a global scale.